James B. Renacci sold CEPHEID (CPHO) (CPHO)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in CEPHEID (CPHO) (CPHO) since 2016, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of CEPHEID (CPHO) (CPHO) on September 9, 2016. Since that trade, CPHO is up +0.00% against the S&P 500 up +307.21%, an outperformance of -307.21%.
Data updated
James B. Renacci's CPHO trades vs the price
CPHO is up +0.00% since James B. Renacci sold on September 9, 2016, versus +307.21% for the S&P 500.
Performance since this trade
All James B. Renacci CPHO trades
James B. Renacci & CPHO trading FAQ
Is it legal for James B. Renacci to trade CEPHEID (CPHO) (CPHO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CEPHEID (CPHO) (CPHO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell CPHO?
James B. Renacci disclosed a sale of $1,000 - $15,000 of CEPHEID (CPHO) (CPHO) on September 9, 2016, according to public STOCK Act filings.
How has CPHO performed since James B. Renacci's trade?
Since James B. Renacci sold CPHO on September 9, 2016, the stock is up +0.00%, versus +307.21% for the S&P 500 over the same period, an outperformance of -307.21%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CPHO trades?
Quantellect tracks every disclosed congressional trade in CEPHEID (CPHO) (CPHO) on the CEPHEID (CPHO) congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's CPHO tradesAll congressional filings for CEPHEID (CPHO)James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.